| scholarly article | Q13442814 |
| P2093 | author name string | Y. Zhang | |
| B. J. Rollins | |||
| P2860 | cites work | Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails | Q24310185 |
| Crystal structure of interleukin 8: symbiosis of NMR and crystallography | Q27658056 | ||
| Three-dimensional structure of interleukin 8 in solution | Q27671809 | ||
| The three-dimensional structure of bovine platelet factor 4 at 3.0-A resolution | Q27728499 | ||
| The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution | Q27729945 | ||
| High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR | Q27731247 | ||
| The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations | Q28247570 | ||
| Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant | Q28252699 | ||
| Monomer-dimer equilibria of interleukin-8 and neutrophil-activating peptide 2. Evidence for IL-8 binding as a dimer and oligomer to IL-8 receptor B | Q28254369 | ||
| Isolation, crystallization, and primary amino acid sequence of human platelet factor 4 | Q28297636 | ||
| Monocyte chemotactic protein 1 is a potent activator of human basophils | Q28305920 | ||
| Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues | Q34059219 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| Neutrophil activation by monomeric interleukin-8. | Q34662590 | ||
| Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors | Q35034275 | ||
| Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. | Q35811725 | ||
| Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis | Q35821357 | ||
| Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils | Q36230940 | ||
| Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line | Q36356054 | ||
| Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants | Q36356057 | ||
| Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. | Q36453167 | ||
| Biology of the rantes/sis cytokine family | Q36678387 | ||
| Properties of the novel proinflammatory supergene "intercrine" cytokine family. | Q37357898 | ||
| Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 | ||
| Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. | Q41461738 | ||
| Suppression of tumor formation in vivo by expression of the JE gene in malignant cells | Q41680734 | ||
| Cross-linking of human neutrophil surface proteins to iodinated interleukin 8 or neutrophil activating peptide-2 results in at least four separable proteins | Q72327496 | ||
| Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations | Q72773324 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4851-4855 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer | |
| A Dominant Negative Inhibitor Indicates that Monocyte Chemoattractant Protein 1 Functions as a Dimer | |||
| P478 | volume | 15 |
| Q40476389 | A novel protein derived from the MUC1 gene by alternative splicing and frameshifting. |
| Q37260178 | AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice |
| Q28080582 | Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries |
| Q36882279 | An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. |
| Q35597994 | Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. |
| Q44497452 | Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice |
| Q44183029 | Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats |
| Q45875756 | Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys |
| Q46735797 | Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats |
| Q27631819 | CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure |
| Q37429204 | Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. |
| Q36916411 | Chemerin reveals its chimeric nature |
| Q33810517 | Chemokine receptor oligomerization and allostery |
| Q34575325 | Chemokine receptors: multifaceted therapeutic targets |
| Q35925887 | Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins |
| Q38170067 | Chemokines and their receptors in intracerebral hemorrhage |
| Q37583987 | Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? |
| Q28392730 | Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure |
| Q37198842 | Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican |
| Q35922575 | Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1). |
| Q46780473 | Dominant negative MCP-1 blocks human osteoclast differentiation |
| Q45172377 | Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice |
| Q38819497 | Exploiting agonist biased signaling of chemokines to target cancer. |
| Q40933898 | Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells |
| Q36698258 | Gene therapy for the prevention of vein graft disease |
| Q27618367 | Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants |
| Q28207703 | Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer |
| Q77762677 | Identification of noncovalent dimeric complexes of the recombinant murine S100 protein CP10 by electrospray ionization mass spectrometry and chemical cross-linking |
| Q24531525 | Identification of oligopeptide sequences which inhibit migration induced by a wide range of chemokines |
| Q36756957 | Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo |
| Q38391456 | MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma |
| Q29614283 | MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity |
| Q46918410 | MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation |
| Q34067117 | Mapping of MCP-1 functional domains by peptide analysis and site-directed mutagenesis |
| Q42044926 | Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage |
| Q37394615 | Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion |
| Q33929458 | Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor |
| Q37481208 | Monocyte chemoattractant protein-1 (MCP-1): an overview |
| Q38139823 | Monocyte chemoattractant protein-1 and the blood-brain barrier |
| Q45999198 | Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. |
| Q92538377 | More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis |
| Q35085550 | Mouse MCP1 C-terminus inhibits human MCP1-induced chemotaxis and BBB compromise |
| Q38965249 | Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer |
| Q28349180 | Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis |
| Q48912595 | Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. |
| Q33598951 | Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response |
| Q33671394 | Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles. |
| Q55004939 | Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion. |
| Q41657939 | New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road |
| Q34345734 | Novel process of intrathymic tumor-immune tolerance through CCR2-mediated recruitment of Sirpα+ dendritic cells: a murine model. |
| Q36818315 | Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus |
| Q34534094 | Proteomic analysis of aorta and protective effects of grape seed procyanidin B2 in db/db mice reveal a critical role of milk fat globule epidermal growth factor-8 in diabetic arterial damage |
| Q41120279 | Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines |
| Q36164454 | Renaming cytokines: MCP-1, major chemokine in pancreatitis |
| Q38114832 | Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases |
| Q34170906 | Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks |
| Q35031917 | Strategies for chemokine antagonists as therapeutics |
| Q42175860 | Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1. |
| Q27639920 | Structural basis of chemokine sequestration by a herpesvirus decoy receptor |
| Q47614473 | Structural characterisation and functional significance of transient protein-protein interactions |
| Q24292437 | Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions |
| Q41478095 | Structure and function of leukocyte chemoattractant receptors |
| Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
| Q34181442 | The C Terminus of Mouse Monocyte Chemoattractant Protein 1 (MCP1) Mediates MCP1 Dimerization while Blocking Its Chemotactic Potency |
| Q35103605 | The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation |
| Q42544286 | The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation. |
| Q40854020 | The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines |
| Q51795920 | The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor. |
| Q41716944 | The molecular and cellular biology of the chemokines |
| Q82230494 | The peptide of sequence 66-77 of monocytic chemotactic protein (MCP-1) inhibits inflammation in experimental animals |
| Q27620649 | The solution structure of the anti-HIV chemokine vMIP-II |
| Q27734322 | The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions |
| Q99551271 | Viromers as carriers for mRNA-mediated expression of therapeutic molecules under inflammatory conditions |
| Q37484542 | X-ray structure analysis of a designed oligomeric miniprotein reveals a discrete quaternary architecture. |
Search more.